CIK 0000925741 · Non-accelerated filer<br>Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232753988
- Phone
- 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- Open-market buys, last 90 days
- $9,394
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,394. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-11 | Altman Peter President and CEO | Purchase | +1,400 | $1.86 | $3K | 332,947 |
| 2022-11-10 | Altman Peter President and CEO | Purchase | +3,100 | $1.87 | $6K | 331,547 |
| 2022-10-10 | McClung David Chief Financial Officer | Purchase | +2,000 | $2.07 | $4K | 78,518 |
| 2022-09-23 | Altman Peter President and CEO | Purchase | +1,400 | $1.87 | $3K | 328,447 |
| 2022-09-22 | Altman Peter President and CEO | Purchase | +3,100 | $1.81 | $6K | 327,047 |
| 2022-09-21 | Altman Peter President and CEO | Purchase | +2,750 | $1.92 | $5K | 323,947 |
| 2022-06-10 | MOYES JAY M Director | Grant or award · Stock Option (right to buy) | +12,434 | 28,789 | ||
| 2022-06-10 | Allen Jim L. Director | Grant or award · Stock Option (right to buy) | +12,434 | 24,868 | ||
| 2022-06-10 | ZSEBO KRISZTINA M Director | Grant or award · Stock Option (right to buy) | +12,434 | 24,868 | ||
| 2022-06-10 | Blank Andrew Scott Director | Grant or award · Stock Option (right to buy) | +12,434 | 24,868 | ||
| 2022-06-10 | STERTZER SIMON H Director | Grant or award · Stock Option (right to buy) | +12,434 | 35,076 | ||
| 2022-06-10 | KRASNO RICHARD M Director | Grant or award · Stock Option (right to buy) | +12,434 | 24,868 | ||
| 2022-06-10 | Altman Peter President and CEO | Purchase | +4,500 | $1.46 | $7K | 321,197 |
| 2022-05-13 | Altman Peter President and CEO | Grant or award | −3,498 | $1.37 | $5K | 348,943 |
| 2022-05-13 | Altman Peter President and CEO | Purchase | +2,698 | $1.38 | $4K | 348,143 |
| 2022-05-12 | McClung David Chief Financial Officer | Grant or award | −17,347 | $1.32 | $23K | 79,803 |
| 2022-05-12 | Altman Peter President and CEO | Shares withheld for taxes | −26,458 | $1.32 | $35K | 321,685 |
| 2022-05-12 | Altman Peter President and CEO | Shares withheld for taxes | −31,446 | $1.32 | $42K | 316,697 |
| 2022-05-12 | GILLIS EDWARD M Senior Vice President, Devices | Shares withheld for taxes | −12,358 | $1.32 | $16K | 23,879 |
| 2022-05-12 | McClung David Chief Financial Officer | Shares withheld for taxes | −20,632 | $1.32 | $27K | 76,518 |
Page 10 of 14 · 273 trades